| |
|
|
|
Eiger BioPharmaceuticals Inc.  
|
|
9.51 -0.13 (-0.01%) |
07-02 16:00 |
|
Open: |
9.86 |
Pre close: |
9.64 |
Target:
|
13.21 
|
|
High: |
9.86 |
Low: |
9.41 |
Resistance:
|
11.31
12.52
|
|
Volume: |
225,861 |
Market Cap: |
238M |
Support:
|
9.35
7.78
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.61
|
MACD |
MACD(12,26):
|
-0.35 |
|
MA(20): |
10.37 |
Signal(12,26,9): |
-0.20 |
|
MA(100): |
9.36 |
Stochastic Oscillator |
%K(14,3):
|
10.77 |
|
MA(250): |
10.77 |
%D(3): |
12.77 |
|
Average Volume(K) |
3-Month: |
36459
|
52-Week |
High:
|
15.82 |
|
10-Days: |
28191 |
Low: |
4.55 |
|
RSI |
RSI(14):
|
37.02 |
Change(%): |
-16.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.830 |
Return on Equity (ttm) |
-145.3 |
Shares Out. (M) |
25.06 |
|
EPS Est. Current Year |
-5.200 |
Return on Assets (ttm) |
-45.2 |
Shares Float (M) |
20.84 |
|
EPS Est. Next Year |
-4.860 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.70 |
|
EPS Est. Next Quarter |
-1.310 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
85.05 |
|
Forward EPS |
-3.080 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
588 |
|
Book Value (p.s.) |
1.760 |
EBITDA (p.s.) |
-2.618 |
P/E |
-3.36 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
5.40 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-62.47 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-36.67 |
P/CF |
-3.81 |
|
|
|
|
|
|
